| Literature DB >> 28017965 |
A García-Hermoso1, R J M Ceballos-Ceballos1, C E Poblete-Aro1, A C Hackney2, J Mota3, R Ramírez-Vélez4.
Abstract
BACKGROUND/Entities:
Mesh:
Substances:
Year: 2016 PMID: 28017965 PMCID: PMC5382285 DOI: 10.1038/ijo.2016.230
Source DB: PubMed Journal: Int J Obes (Lond) ISSN: 0307-0565 Impact factor: 5.095
Figure 1Flow chart for identification of trials for inclusion in the meta-analysis.
Characteristics of the studies included in the meta-analysis
| n | n | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balagopal | 8 | 15.6 | Aerobic+Resistance | 7 | 15.9 | ⩾p97 | 12 | 3 | 45 | NR | NR | Leptin |
| Balagopal | 8 | 15.6 | Aerobic+Resistance | 7 | 15.9 | ⩾p97 | 12 | 3 | 45 | NR | NR | Adiponectin |
| Chae | 19 | 10.4 | Aerobic+Resistance | 19 | 10.6 | ⩾p97 | 12 | 2 | 90 | NR | NR | Adiponectin |
| Fazelifar | 12 | 11–13 | Aerobic+Resistance | 12 | 11–13 | ⩾28 | 12 | 3 | 10–30 | 50–85 HRmax | NR | Adiponectin |
| Jeon | 8 | 11.0 | Aerobic+Resistance | 7 | 11.0 | ⩾p85 | 12 | 2 | 50 | 55–75 HRmax | NR | Adiponectin |
| Karacabey[ | 20 | 11.8 | Aerobic | 20 | 11.2 | >30 | 12 | 3 | 30–65 | 60–65 HRmax | NR | Leptin |
| Kelly | 9 | 10.8 | Aerobic | 10 | 11.0 | ⩾p85 | 8 | 4 | 30 | 50–60 HRmax | NR | Leptin, Adiponectin, Resistin |
| Kim | 14 | 17.0 | Aerobic | 12 | 17.0 | NR | 6 | 5 | 40 | NR | NR | Adiponectin |
| Kim | 18 | 17.6 | Aerobic | 12 | 17.4 | ⩾25 | 12 | 5 | 50 | NR | NR | Adiponectin |
| Lee | 11 | 16.9 | Aerobic | 7 | 16.9 | ⩾25 | 12 | 3 | 30–40 | 60–80 HRmax | NR | Visfatin |
| Nunes | 17 | 16.8 | Aerobic+Resistance | 8 | 15.4 | ⩾p95 | 24 | 4 | 60 | 60–100 VO2peak | NR | Adiponectin |
| Park | 15 | 12.1 | Aerobic+Resistance | 14 | 12.2 | ⩾p85 | 12 | 3 | 80 | 50–70 HRreserve | 90 | Leptin, Adiponectin |
| Racil | 11 11 | 15.6 16.3 | Anerobic Aerobic | 12 | 15.9 | ⩾p97 | 12 | 4 | 20 | 100–110 VO2peak 70–80 VO2peak | NR | Adiponectin |
| Vasconcellos | 10 | 14.1 | Aerobic | 10 | 14.8 | ⩾2 s.d. | 12 | 3 | 60 | 84.8 HRmax | NR | Leptin, Adiponectin, Resistin |
Abbreviations: CG, control group; EG, experimental group; HIIT, high-intensity interval training; HR, heart rate; MIIT, moderate-intensity interval training; NR, not reported; p, percentile; Se, session; W, week.
Figure 2Absolute changes in adiponectin, leptin, and resistin levels in individual studies of exercise group vs control group. HIIT indicates High-Intensity Interval Training. MIIT indicates Moderate-Intensity Interval Training.
Figure 3Exercise training–induced adipokines have an endocrine effect and improve whole-body metabolism. We propose a model whereby exercise causes release adipokines (decrease leptin and resistin, and increasing adiponectin), which can act in an endocrine manner to improve metabolism in skeletal muscle, white adipose tissue and liver.